General hospital and personal-use devices associated with adverse incidents

VWXY20_GENERAL_HOSPI_PERSONAL__DEVICES_ASSOCIATED_W_ADVER_INCIDENTS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Y74 Cause of death: ICD-10 — Y74 2 out of 7 registries used, show all original rules.	61
4. Check minimum number of events None	61
5. Include endpoints None	61
6. Filter based on genotype QC (FinnGen only)	57

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Y7|Y8[0-2]

NAME	VWXY20_GENERAL_HOSPI_PERSONAL__DEVICES_ASSOCIATED_W_ADVER_INCIDENTS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Y74
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Y74
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to General hospital and personal-use devices associated with adverse incidents based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	57	27	30
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	49.75	43.40	55.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
58: Matched controls
580

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Y74

ICD-10 Finland

General hospital and personal-use devices associated with adverse incidents

+∞

56.9

ZXE00

NOMESCO Finland

One hour or less

6.4

10.7

150

R4110

NOMESCO Finland

Physiotherapy

5.8

10.2

108

Z2221

NOMESCO Finland

Medical doctor

5.3

9.1

ZXD10

NOMESCO Finland

Scheduled procedure

5.1

8.7

140

Z3231

NOMESCO Finland

Registered nurse

4.7

7.8

Y74.8

ICD-10 Finland

General hospital and personal-use devices associated with adverse incidents, miscellaneous devices, not elsewhere classified

+∞

7.4

Z3226

NOMESCO Finland

Physiotherapist

4.7

6.9

ZXE10

NOMESCO Finland

More than one and less than three hours

4.2

6.8

125

R03BB04

ATC

tiotropium bromide; inhalant

8.0

6.7

ZXD05

NOMESCO Finland

Urgent procedure

4.1

6.6

127

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6.11

10.16

4.2

2.5

1.50

2.88

e6/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5.56

9.29

4.2

2.4

1.23

0.93

e6/l

—

(3030467) Casts [#/volume] in Urine by Automated count

131

3.67

5.61

4.7

2.8

0.22

0.31

e6/l

0.21

(3002582) Erythrocytes [#/volume] in Urine

153

3.43

5.08

4.6

2.9

44.81

444.05

e6/l

0.48

121

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3.88

4.70

2.2

3.0

4.24

14.49

umol/l

0.87

(3018095) Leukocytes [#/volume] in Urine

179

3.17

4.44

5.9

3.5

75.61

54.97

e6/l

0.27

126

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3.09

3.81

4.7

3.8

3322.69

33.48

ng/l

0.47

(3049717) Cytology report of Urine Cyto stain

8.65

3.67

1.7

2.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

5.71

3.53

1.3

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

0.00

3.05

0.0

5.3

—

32.13

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.86

2.73

3.5

7.8

104.00

103.84

mmol/l

0.05

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.42

2.67

1.5

1.6

—

(3021589) Normoblasts [#/volume] in Blood

200

2.34

2.54

9.4

10.9

0.00

e9/l

0.12

159

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.76

2.45

1.1

1.9

—

(3018418) pH of Serum or Plasma

143

2.32

2.41

3.7

4.9

7.39

0.23

(3000492) Spirometry study

2.89

2.36

1.5

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3.36

2.26

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

5.95

2.26

1.2

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

5.95

2.26

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4.04

2.23

1.9

1.7

—

(3023368) Bacteria identified in Blood by Culture

137

2.12

1.94

5.7

4.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

266

2.08

1.87

10.4

9.0

4.25

4.16

e9/l

0.08

233

(3001604) Monocytes [#/volume] in Blood

232

1.98

1.73

7.3

5.0

0.58

0.60

e9/l

0.16

200

(3000494) Fungus identified in Specimen by Culture

2.39

1.69

1.2

1.9

—

(42870588) Differential panel, method unspecified - Blood

152

1.99

1.68

6.1

5.2

—

(3006315) Basophils [#/volume] in Blood

234

1.95

1.66

7.3

5.0

0.05

0.04

e9/l

1.02

200

(40768797) Stomach Pathology biopsy report

2.24

1.66

1.6

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.80

1.65

1.2

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

201

0.44

1.64

2.9

3.6

21.20

22.47

ng/l

—

135

(3003327) Ova and parasites identified in Stool by Light microscopy

3.22

1.62

1.0

1.8

—

(3013115) Eosinophils [#/volume] in Blood

246

1.92

1.59

7.4

5.4

0.21

0.18

e9/l

0.33

212

(36660697) Celiac disease serology panel - Serum

2.69

1.56

1.2

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

3.54

1.55

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

238

1.90

1.55

7.3

5.2

1.72

2.09

e9/l

0.76

211

(3024561) Albumin [Mass/volume] in Serum or Plasma

203

1.86

1.47

7.0

6.1

34.97

35.66

g/l

0.25

197

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

3.32

1.47

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

141

1.90

1.46

1.9

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

102

1.94

1.35

1.6

1.2

2.29

2.47

g/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

127

1.88

1.35

2.9

2.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

217

1.79

1.33

2.5

2.2

83.71

95.61

pmol/l

0.74

109

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.94

1.31

1.8

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.34

1.27

1.3

1.8

—

(3045424) Erythrocytes [Presence] in Urine

0.00

1.20

0.0

2.2

—

0.00

—

(21494755) Public health laboratory ask at order entry panel

2.18

1.11

1.0

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2.51

1.11

1.0

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.07

1.09

1.8

1.7

—

(1761868) Lipid panel - Serum or Plasma

195

0.57

0.95

2.6

3.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.95

0.95

1.3

4.4

3.02

20.96

ug/l

—

(3022145) Colonoscopy Study observation

1.95

0.95

1.2

1.3

—

(3015736) pH of Urine

207

1.57

0.87

4.1

3.3

5.78

6.21

—

117

(3044640) Blood type and Crossmatch panel - Blood

171

1.57

0.84

3.1

2.7

—

(3042936) Bacteria identified in Isolate by Culture

1.84

0.82

2.4

2.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.71

0.80

2.5

2.8

21.23

25.32

0.51

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.79

0.79

1.9

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.18

0.76

1.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.65

0.74

1.9

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

112

1.59

0.74

3.1

2.3

—

(3000991) Gas panel - Venous blood

1.80

0.73

3.9

10.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.64

0.71

1.8

1.7

—

(3035941) MCH [Entitic mass]

517

0.58

0.67

38.9

24.0

30.04

30.45

1.12

511

(3024731) MCV [Entitic mean volume] in Red Blood Cells

517

0.58

0.67

38.8

24.0

90.72

91.15

0.30

511

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

517

0.58

0.67

39.3

24.6

40.29

40.66

0.29

510

(3007461) Platelets [#/volume] in Blood

517

0.58

0.67

38.9

24.1

261.06

246.58

e9/l

1.00

506

(3000963) Hemoglobin [Mass/volume] in Blood

517

0.58

0.67

39.1

24.3

133.23

136.29

g/l

0.89

510

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.79

0.65

1.8

3.6

24.60

23.78

mmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

237

1.45

0.64

3.5

3.2

—

estimate

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.55

0.62

2.4

1.4

—

(4034850) Laboratory test

0.00

0.61

0.0

17.4

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.61

0.0

3.0

—

101.57

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.85

0.61

3.2

5.9

24.73

24.71

mmol/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.59

0.0

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

101

1.51

0.56

2.7

3.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

505

0.63

0.55

34.4

20.8

76.74

78.42

umol/l

0.18

499

(3026008) Bacteria identified in Urine by Culture

147

1.44

0.55

3.8

2.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.51

0.54

3.1

2.9

12.51

14.43

umol/l

0.45

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

459

0.69

0.51

5.3

5.6

5.89

5.92

mmol/l

0.05

419

(3031040) Bacteria [#/volume] in Urine by Automated count

325

1.38

0.50

6.3

4.4

—

119.80

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

217

1.36

0.48

5.1

9.6

1.24

1.21

mmol/l

0.99

200

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1.42

0.42

1.5

1.2

—

47.29

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.42

0.0

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.42

0.0

2.3

—

4.01

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.42

0.0

2.9

—

(3002256) Pathology report gross observation

1.45

0.41

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.41

0.0

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.47

0.40

1.6

3.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.36

0.39

5.1

2.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.34

0.34

3.3

8.4

1.70

1.20

mmol/l

—

(3003396) Base excess in Arterial blood by calculation

1.34

0.32

4.7

16.8

0.64

0.67

mmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

309

1.24

0.28

2.9

3.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.30

0.27

1.9

1.8

—

(40758558) Short blood count panel - Blood

143

1.27

0.27

10.0

6.8

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.27

0.23

2.0

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

481

0.79

0.22

28.6

15.3

22.46

24.07

mg/l

0.17

399

(3010726) Horse dander IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.18

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(4035726) Immunohistochemistry procedure

1.28

0.21

1.8

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.20

0.0

4.4

—

28.44

—

(3017732) Neutrophils [#/volume] in Blood

0.71

0.18

1.6

4.1

3.58

4.43

e9/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.10

0.10

1.4

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.07

0.10

2.0

3.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.05

0.08

2.9

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.06

0.08

7.0

2.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

148

1.11

0.07

3.9

3.2

46.31

57.80

u/l

0.85

138

(40761511) CBC panel - Blood by Automated count

489

0.89

0.04

15.5

14.7

—

(3019150) Specific gravity of Urine by Refractometry

107

0.92

0.02

4.7

3.9

1.01

1.02

kg/l

—

(3032080) INR in Blood by Coagulation assay

247

1.02

0.00

21.0

13.9

1.29

1.25

inr

0.11

199

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

135

1.05

0.00

4.9

17.56

23.78

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3011648) Oxygen content in Venous blood

0.00

0.0

1.8

—

9.72

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.0

3.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

77.50

—

(21494815) CD4 cells/Lymphocytes in Specimen

0.00

0.0

2.0

—

40.55

—

(3011412) CD3 cells [#/volume] in Blood

0.00

0.0

1.3

—

1552.83

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

191.80

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

119.83

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.0

1.0

—

(3012441) Differential panel - Pleural fluid

0.00

0.0

1.5

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

1.6

—

(3023419) Bacteria identified in Sputum by Culture

0.00

-0.00

0.0

2.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40768804) Tissue Pathology biopsy report

200

1.00

-0.00

1.9

2.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

-0.00

0.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

0.91

-0.00

2.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.6

—

213.00

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

1.4

—

(3025130) Human papilloma virus identified in Specimen

0.00

-0.00

0.0

3.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

4.4

—

133.33

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

-0.00

0.0

1.5

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

-0.00

0.0

1.4

—

11.14

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(3035715) Granulocytes [#/volume] in Blood

0.00

-0.00

0.0

1.7

—

4.63

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

2.5

—

(3035933) Granulocytes/Leukocytes in Blood

0.00

-0.00

0.0

1.6

—

58.22

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

3.90

—

(3010503) CD19 cells [#/volume] in Blood

0.00

-0.00

0.0

1.4

—

161.20

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.87

-0.00

1.4

1.6

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_GENERAL_HOSPI_PERSONAL__DEVICES_ASSOCIATED_W_ADVER_INCIDENTS – General hospital and personal-use devices associated with adverse incidents

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

General hospital and personal-use devices associated with adverse incidents

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for General hospital and personal-use devices associated with adverse incidents (VWXY20_GENERAL_HOSPI_PERSONAL__DEVICES_ASSOCIATED_W_ADVER_INCIDENTS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints